Alvotech (ICE:ALVO)
1,055.00
+35.00 (3.43%)
At close: Oct 7, 2025
Alvotech Employees
Alvotech had 1,012 employees as of December 31, 2024. The number of employees increased by 13 or 1.30% compared to the previous year.
Employees
1,012
Change (1Y)
13
Growth (1Y)
1.30%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
328.05B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,012 | 13 | 1.30% |
Dec 31, 2023 | 999 | 82 | 8.94% |
Dec 31, 2022 | 917 | 133 | 16.96% |
Dec 31, 2021 | 784 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Marel | 7,500 |
Íslandsbanki | 764 |
Arion banki | 822 |
Sildarvinnslan Hf. | 723 |
Brim hf. | 694 |
Hagar | 2,699 |
Kvika banki | 270 |
Festi | 1,352 |
Alvotech News
- 16 days ago - European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia® and Xgeva® - GlobeNewsWire
- 16 days ago - European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia® and Xgeva® - GlobeNewsWire
- 16 days ago - European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech's Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner - GlobeNewsWire
- 16 days ago - European Medicines Agency Recommends Marketing Approval of Gobivaz®, Alvotech's Proposed Biosimilar to Simponi® (golimumab) with Advanz Pharma as Commercialization Partner - GlobeNewsWire
- 19 days ago - Alvotech Announces Marketing Approval in Japan of Three New Biosimilars - GlobeNewsWire
- 19 days ago - Alvotech Announces Marketing Approval in Japan of Three New Biosimilars - GlobeNewsWire
- 4 weeks ago - Alvotech (ALVO) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York - GlobeNewsWire